Cycloheximide (CHX)^1^ is a protein synthesis inhibitor that has been widely used in studies of programmed cell death or apoptosis. Apoptosis and necrosis are two different forms of cell death whose distinguishing characteristics are based largely on morphological features (see [@B83]; for review see [@B78]). Cells dying by apoptosis undergo shrinkage, cell surface blebbing, and DNA condensation and fragmentation; their membranes remain intact as the cell dies. In contrast, cells dying by necrosis swell and lyse. Neuronal apoptosis has been most commonly studied in paradigms of natural developmental cell death in which withdrawal of trophic factor support initiates the cell death program ([@B18]). However, it is becoming increasingly recognized that apoptosis also occurs in both acute and chronic neurodegenerative conditions in the adult nervous system. For example, neurons may die by apoptosis in cerebral ischemia ([@B50]; [@B47]), epilepsy ([@B70]), Huntington\'s disease ([@B71]), and Alzheimer\'s disease (for review see [@B17]). CHX delays or prevents the death of neurons subjected to a range of insults. For example, CHX prevents apoptosis of cultured sympathetic neurons induced by withdrawal of NGF ([@B56], 1992) and also prevents trophic factor deprivation--induced death of PC12 cells ([@B69]). In addition, CHX protects: cultured retinal ganglion cells against excitotoxicity ([@B21]); PC12 cells against glutamate toxicity ([@B76]); adult cortical neurons against ischemic injury in vivo ([@B30]; [@B47]; [@B82]); adult septal neurons against NGF withdrawal in vivo ([@B80]); cultured striatal and cortical neurons against the toxicity of 3-nitropropionic acid ([@B6]); cultured cortical neurons against oxidative stress-induced death ([@B72]); and cultured cortical neurons against amyloid β-peptide (Aβ) toxicity ([@B81]). One widely accepted interpretation of the ability of CHX to protect neurons is that it prevents the synthesis of "killer" gene products (for review see [@B74]). However, that mechanism of CHX action has not been firmly established and alternative explanations exist, including the quite opposite possibility that CHX induces the expression of cytoprotective gene products. Indeed, CHX is well known to induce increases in levels of an array of immediate early gene mRNAs ([@B10]; [@B68]), and recent findings suggest that CHX can activate kinases such as mitogen-activated protein kinase ([@B86]) known to be involved in neurotrophic factor signaling cascades ([@B75]).

Data from a variety of cell death paradigms ranging from withdrawal of trophic factor support in sympathetic neurons ([@B32]), excitotoxicity ([@B7]; [@B65]), metabolic impairment ([@B4]), and Aβ toxicity ([@B61]; [@B5]; [@B29]) suggest that free radicals and disruption of calcium homeostasis are convergence points in the cell death process in both apoptosis and necrosis. Further evidence supporting common mechanisms of apoptotic and necrotic neuronal death comes from studies showing that the same neurotrophic factor can protect neurons against death induced by the range of insults mentioned above including: withdrawal of trophic support ([@B18]); excitotoxicity ([@B60], 1995); metabolic insults ([@B12]; [@B46]); cerebral ischemia ([@B43]); and Aβ toxicity ([@B61]; [@B29]). General mechanisms of neuroprotection appear to involve induction of the expression of proteins involved in suppressing free radical accumulation (e.g., antioxidant enzymes) and stabilizing ion homeostasis (e.g., calcium-binding proteins) (for review see [@B62]). For example, NGF, basic FGF (bFGF), and brain-derived neurotrophic factor (BDNF) increased to varying degrees activities of one or more antioxidant enzymes (Cu/Zn--superoxide dismutase \[SOD\], catalase, glutathione peroxidase, and glutathione reductase) in hippocampal cell cultures ([@B65]). Data suggest that BDNF can also induce expression of the antiapoptotic gene product bcl-2 ([@B2]), which is believed to function in antioxidant pathways ([@B36]). bcl-2 can delay cell death when overexpressed in a variety of cell paradigms of apoptotic and necrotic cell injury ([@B35]; [@B58]; [@B8]; [@B11]; [@B48]; [@B45]). Sympathetic neurons from mice deficient in *bcl-2* die more rapidly after NGF withdrawal than do sympathetic neurons from wildtype mice ([@B33]). These kinds of data led us to propose that cell death, whether apoptotic or necrotic, occurs when activation of cell life programs is not sufficient to overcome the level of stress (oxidative or ionic) imposed upon the neuron ([@B59]). Because neurotrophic factors protect neurons against death in many of the same paradigms in which CHX is neuroprotective, we tested the hypothesis that CHX protects neurons by a mechanism similar to neurotrophic factors, namely, by inducing cytoprotective gene products.

Materials and Methods
=====================

Hippocampal Cell Cultures and Experimental Treatments
-----------------------------------------------------

Dissociated cell cultures of fetal rat hippocampus were established from 18-d embryos and maintained as described previously ([@B60], 1995). Cells were plated in 35-mm-diam plastic or glass-well dishes on a polyethyleneimine substrate in 0.8 ml of medium consisting of MEM with Earle\'s salts supplemented with heat-inactivated FBS (5%; vol/vol), 1 mM l-glutamine, 1 mM pyruvate, 20 mM KCl, and 26 mM sodium bicarbonate (pH 7.2). Cells were grown at a density of 80--120 cells per mm^2^ culture surface, and experiments were performed in 8--10-d-old cultures, a time period during which neurons express both *N*-methyl-d-aspartate (NMDA) and non-NMDA glutamate receptors, and are vulnerable to excitotoxicity ([@B63]), Aβ toxicity ([@B61]), and FeSO~4~ toxicity ([@B85]). Cycloheximide, glutamate, buthionine sulfoximine, and FeSO~4~ were purchased from Sigma Chemical Co. (St. Louis, MO) and prepared as 200--500 × stocks in saline (pH 7.2). Aβ25-35 (lot ZM500) was purchased from Bachem California (Torrance, CA) and stored in lyophilized form, and 1 mM stocks were prepared by dissolving the peptide in sterile distilled water 2--4 h before use. Oligodeoxynucleotides (ODNs) were purchased from IDT Inc. (Coralville, IA). The sequence of the Bcl-2 antisense ODN was 5′-TCCCGGCTTGCGCCAT-3′. Three different control ODNs were used: sense ODN; missense ODN, 5′-TCGCGGCATGCCCCAT-3′; and nonsense ODN, 5′-CTGTCGCGCTCGACTC3′. Immediately before experimental treatment, the culture maintenance medium was replaced with Locke\'s solution that had the following composition (mM): 154 NaCl; 5.6 KCl; 2.3 CaCl~2~; 1.0 MgCl~2~; 3.6 NaHCO~3~; 5 Hepes; 10 glucose.

Quantification of Neuron Survival
---------------------------------

These methods are detailed in our previous studies ([@B60], 1995). Briefly, viable neurons were counted in premarked microscope fields (×10 objective) before experimental treatment and 20--24 h after treatment. Most neurons that died during the exposure period to glutamate, FeSO~4~, or Aβ were absent at the 20-h time point, and viability of the remaining neurons was assessed by morphological criteria. Neurons with intact neurites of uniform diameter and a soma with a smooth appearance were considered viable. Neurons with fragmented neurites and a vacuolated and/or swollen soma were considered nonviable.

Protein Synthesis Assay
-----------------------

These methods were those described previously ([@B57]). Cultures (incubated in methionine- and cysteine-free medium) were pretreated with vehicle or CHX, and then \[^35^S\]methionine/cysteine (ICN Radiochemicals, Irvine, CA; sp act \>1,000 Ci/mmol) was added to a final concentration of 25 μCi/ml (in the continued presence of CHX). 30 min later, cultures were washed once with medium, and 2 ml of a solution containing 0.5% SDS, 1 mM EDTA, 10 mM Tris (pH 7.5) was added. 40 μg of BSA was added to each sample, and protein was precipitated with 10% TCA on ice. Precipitated protein was collected by filtration onto 0.45-μm nitrocellulose filters. Filters were washed twice with cold 10% TCA and dried, and radioactivity was quantified in a liquid scintillation counter.

PCR Analyses
------------

Analyses of gene expression were performed as described previously ([@B24]). Briefly, polyA+ RNA was isolated from cells after the indicated treatments by using an oligo-dT--cellulose-based purification kit (QuickPrep Micro kit; Pharmacia Fine Chemicals, Piscataway, NJ) and concentrated by coprecipitation with glycogen, all as directed by the manufacturer. Half of the mRNA was converted to cDNA by reverse transcription (RT) by using random hexamers (16 μM) to prime Moloney murine leukemia virus reverse transcriptase (Superscript; Life Technologies, Grand Island, NY). The 30-μl reaction contained 50 mM Tris (pH 8.3), 40 mM KCl, 6 mM MgCl~2~, 1 mM DTT, 500 μM each dATP, dTTP, dCTP, dGTP, and 20 U RNasin (Promega, Madison, WI). After 10 min at 20°C, the samples were incubated for 50 min at 42°C, and the reaction was then terminated by heating to 94°C for 5 min.

For PCR amplification of specific cDNAs, stock reactions (50 μl) were prepared on ice and contained 50 μM dCTP, 100 μM each dGTP, dATP, and dTTP, 15 μCi α-\[^32^P\]dCTP (3,000 Ci/mmol), 1.5 mM MgCl~2~, 50 mM KCl, 10 mM Tris (pH 9.0), 0.1% Triton X-100, 1 μM each primer, 1 U of Taq polymerase, and 3% of the cDNA synthesized in the RT reaction. The sequences of the primers used in this study were: *NFM* sense primer: 5′ ACG CTG GAC TCG CTG GGC AA 3′, *NFM* antisense primer: 5′ GCG AGC GCG CTG CGC TTG TA 3′ (156-bp product); c-jun sense primer: 5′ ACT CAG TTC TTG TGC CCC AA 3′, c-jun antisense primer: 5′ CGC ACG AAG CCT TCG GCG AA 3′ (64-bp product); c-*fos* sense primer: 5′ AAT AAG ATG GCT GCA GCC AA, c-*fos* antisense primer: 5′ TTG GCA ATC TCG GTC TGC AA 3′ (116-bp product); *bcl-2* sense primer: 5′-CTGTACGGCCCCAGCATGCG-3′, *bcl-2* antisense primer: 5′-GCTTTGTTTCATGGTACATC-3′ (210-bp product). The stock solutions were separated into three equal aliquots that were covered with a drop of mineral oil and subjected to various numbers of PCR cycles to determine the minimum number of cycles necessary to detect the PCR product. The typical reaction conditions were 1 min at 95°C, 1 min at 55°C, and 2 min at 72°C. The results depicted here represent 16--22 cycles of amplification. After amplification, the cDNAs were separated by electrophoresis on 12% polyacrylamide gels, visualized by autoradiography of the dried gels, and quantified with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). The identity of the PCR product amplified by each primer pair was confirmed typically either by direct sequencing (fmole sequencing kit; Promega), or by subcloning the amplified cDNAs into pBluescript (Stratagene, La Jolla, CA) and then sequencing the inserts.

Immunocytochemistry and Western Blot Analyses
---------------------------------------------

These methods were similar to those described previously ([@B63]; [@B14]). Briefly, cells were fixed in 4% paraformaldehyde, with membranes permeabilized by exposure for 5 min to 0.2% Triton X-100 in PBS, and placed in blocking serum (0.5% horse serum). Cells were then exposed to primary antibody overnight at 4°C, followed by incubation for 1 h with biotinylated anti--mouse IgG, a 30-min incubation in the presence of ABC reagent (Vector Labs, Inc., Burlingame, CA), and a 5-min exposure to DAB tetrahydrochloride. Parallel control cultures were processed identically except that the primary antibody was deleted from the procedure. The primary antibodies were affinity-purified rabbit anti-- c-Fos (1:500) and anti--c-Jun (1:1,000) (Oncogene Science, Inc., Minecola, NY), and mouse monoclonal anti--Bcl-2 (1:500; Santa Cruz Biotechnology, Santa Cruz, CA). Immunostained cultures were visualized under bright-field optics, and relative levels of immunoreactivity of neuronal cell bodies were scored according to the following scale: 0, no immunoreactivity; 1, weak; 2, moderate; 3, intense; 4, very intense. 100 neurons were scored per culture. All cultures were scored without knowledge of their treatment history. For Western blot analysis, solublized proteins were separated by SDS-PAGE (12% gel), transferred to a nitrocellulose sheet, and immunoreacted overnight with Bcl-2 antibody in the presence of blocking serum (1:500). The blot was then exposed for 1 h to HRP-conjugated secondary antibody (1:10,000; Jackson ImmunoResearch Laboratories Inc., West Grove, PA) and immunoreactive protein was visualized using a chemiluminescence-based detection kit according to the manufacturer\'s protocol (ECL kit; Amersham Corp., Arlington Heights, IL).

Measurement of Hydrogen Peroxide Levels
---------------------------------------

These methods were similar to those described previously ([@B29]). Briefly, cells were incubated for 50 min in the presence of 50 μM 2,7-dichlorofluorescin diacetate (DCF; Molecular Probes, Inc., Eugene, OR), and then were washed three times (2 ml per wash) in HBSS containing 10 mM Hepes and 10 mM glucose. Cells were imaged using a confocal laser scanning microscope (Sarastro 2000; Molecular Dynamics) coupled to an inverted microscope (Nikon, Inc., Garden City, NY). Cells were located under visible light and a single image was acquired by scanning with the laser (488-nm excitation and 510-nm barrier filter). The laser intensity and photodetector gain were held constant to allow quantitative comparisons of relative fluorescence intensity of cells between treatment groups. Values of relative DCF fluorescence (average pixel intensity per cell) were obtained using the Imagespace software supplied by the manufacturer (Molecular Dynamics).

Antioxidant Enzyme Activity Assays
----------------------------------

Activities of Cu/Zn-SOD, Mn-SOD, and catalase in cultured cells were quantified by methods described previously ([@B65]). Cells from 60-mm culture dishes were pelleted by low speed centrifugation and homogenized in 2.5 ml of a nitrogen-purged buffer consisting of 10 mM Hepes, 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH~2~PO~4~, 0.6 mM MgSO~4~ (pH 7.4). The homogenate was centrifuged for 1 h at 100,000 *g* at 4°C, and the supernatant was used for enzyme assays. For the SOD activity assay, 200 μl of the supernatant was added to 1.48 ml of 68 mM NaH~2~PO~4~ containing 1.35 mM EDTA (pH 7.8), 100 μl of 4 mM xanthine, and 170 μl of 3.53 mM epinephrine (pH 11.5). After a 5-min incubation at 30°C, 50 μl of xanthine oxidase was added to the cuvette, and the absorbance was followed for 3 min at 320 nm. To control for variability among lots, xanthine oxidase was diluted until an assay mixture without SOD yielded 0.03 A change per min. Mn-SOD activity was taken as the SOD activity remaining after addition of potassium cyanide (200 mM). One unit of SOD activity was defined as the amount that reduced the absorbance change by 50%, and results were expressed as units per mg protein. For the catalase activity assay, cell homogenate supernatant (1.5 ml) was mixed with 18 μl absolute ethanol and incubated on ice for 8 min, and 7.8 μl of 10% Triton X-100 and 2.5 ml of 10 mM NaH~2~PO~4~ buffer (pH 7.4) were added. Aliquots (0.6 ml) of the solution were added to 20-ml test tubes along with 3.57 ml of cold 6 mM hydrogen peroxide and the tube was vortexed. After 3 min, 0.714 ml of 6 N H~2~SO~4~ was added and the mixture was vortexed. 5 ml of 0.01 N KMnO~4~ was added to the solution, the tube was vortexed, and the absorbance was measured at 480 nm within 60 s using a Spec 21 UV-Vis spectrophotometer (Shimadzu, Inc., Kyoto, Japan). Quantitation was based on the comparison of the tissue samples with a calibration curve of known peroxide concentrations. The activity of the enzyme was expressed as units per mg protein with 1 unit = 1 μmol of H~2~O~2~ catalyzed per min.

Results
=======

CHX Protects Hippocampal Neurons against Excitotoxic and Oxidative Injuries in a Concentration-dependent Manner
---------------------------------------------------------------------------------------------------------------

Hippocampal neurons express NMDA and AMPA/kainate receptors and are vulnerable to glutamate-induced excitotoxicity mediated by calcium influx ([@B15]; [@B60]) and generation of reactive oxygen species ([@B44]; [@B22]; [@B65]). Cultured hippocampal neurons are also vulnerable to killing by a variety of oxidative insults including exposure to FeSO~4~ ([@B85]) and to Aβ (see [@B84]; for review [@B52]); Aβ- induced death manifests as apoptosis ([@B49]). Exposure of cultures to 10 μM glutamate, 5 μM FeSO~4~, or 5 μM Aβ resulted in killing 60--70% of the neurons (Fig. [1](#F1){ref-type="fig"}). Pretreatment of cultures with increasing concentrations of CHX for 16 h before exposure to glutamate, FeSO~4~, or Aβ resulted in biphasic concentration-dependent increase in neuronal survival. CHX concentrations of 50--100 nM significantly increased neuronal survival such that 80--90% of the neurons survived exposure to each of the three insults (Fig. [1](#F1){ref-type="fig"}). Concentrations of CHX of ⩾1 μM were ineffective in protecting neurons, and concentrations \>1 μM caused significant neuronal death during a 24-h exposure period (Fig. [1](#F1){ref-type="fig"} *D*).

Neuroprotective Concentrations of CHX Do Not Inhibit Protein Synthesis
----------------------------------------------------------------------

Since the concentrations of CHX that were neuroprotective were below those expected to inhibit protein synthesis maximally, we examined the time course and concentration dependence of CHX effects on incorporation of radiolabeled amino acids into TCA-precipitable protein (Fig. [2](#F2){ref-type="fig"}). Parallel cultures were exposed for increasing times (1, 4, 12, and 24 h) to either 100 nM or 10 μM CHX. In cultures exposed to 100 nM CHX, levels of protein synthesis were reduced to ∼60% of control levels within 1 h of exposure, recovered to ∼80% of control levels by 4 and 12 h, and then decreased somewhat at 24 h (Fig. [2](#F2){ref-type="fig"} *A*). In contrast, levels of protein synthesis in cultures exposed to 10 μM CHX were reduced to 10% of control levels within 1 h of exposure and remained at this low level through 24 h (Fig. [2](#F2){ref-type="fig"} *A*). In a separate experiment, the concentration dependence of inhibition of protein synthesis by CHX was examined in more detail. Levels of protein synthesis were reduced to 60--75% of control levels in cultures exposed to 10--300 nM CHX for 1 h. CHX concentrations of ⩾1 μM caused a \>90% inhibition of protein synthesis.

Neuroprotective Concentrations of CHX Induce Expression of mRNA and Protein for bcl-2, c-fos, and c-jun
-------------------------------------------------------------------------------------------------------

A characteristic set of genes is rapidly induced when neurons are subjected to toxic insults. Perhaps the most widely studied is the immediated early gene *c-fos*, which is induced at both the mRNA and protein levels in neural cells subjected to ischemia ([@B1]; [@B20]), excitotoxins ([@B27]), oxidative insults ([@B67]; [@B28]), and trophic factor withdrawal ([@B66]). We previously used RT-PCR approaches to examine expression of immediate early genes after NGF withdrawal from cultured sympathetic neurons ([@B24]), and after exposure to Aβ in cultured rat cortical neurons ([@B25]). To gain insight into the neuroprotective mechanism of CHX, we determined the effects of CHX on levels of mRNA encoding c-Fos, c-Jun, and the antiapoptotic gene Bcl-2. CHX induced a concentration-dependent increase in levels of *bcl-2*, c-*fos*, and c-jun mRNAs (Fig. [3](#F3){ref-type="fig"}). In the case of *bcl-2* mRNA, a twofold increase occurred in cells exposed to 30 nM CHX, and the peak increase of approximately fivefold occurred in cultures exposed to 100 nM CHX. Higher concentrations of CHX were ineffective in increasing *bcl-2* mRNA levels. In the cases of c-*fos* and c-jun mRNAs, the concentration--response curves were also biphasic and exhibited similar profiles with peak increases occurring in cultures exposed to 100--300 nM CHX (Fig. [3](#F3){ref-type="fig"}). Similar results were obtained in two additional concentration--response experiments using separate cultures. The time course of changes in *bcl-2*, c-*fos* and c-jun mRNAs after exposure to 100 nM CHX is shown in Fig. [3](#F3){ref-type="fig"} *C.* The mRNA levels for each gene increased within 10 min of exposure to CHX, peaked by 30 min, and remained elevated for at least 8 h.

To provide insight into whether the increase of immediate early gene mRNA levels resulted from increased transcription or stabilization of mRNA, we examined levels of c-*fos* heteronuclear RNA (hnRNA) in cultures exposed to increasing concentrations of CHX. At the CHX concentrations that were most effective in protecting neurons against excitotoxicity and oxidative insults (100--300 nM), CHX induced a clear increase in the level of c-*fos* hnRNA (Fig. [4](#F4){ref-type="fig"}). Lower and higher concentrations of CHX had little or no effect on c-*fos* hnRNA levels. Because the concentrations of CHX effective in protecting neurons against glutamate toxicity and oxidative insults were below concentrations that inhibit protein synthesis maximally, and because c-*fos* and *bcl-2* are induced by neurotrophic factors ([@B55]; [@B19]) that can protect neurons against some of the same insults examined in the present study ([@B62],*c*, 1995), we determined the effects of CHX on levels of Bcl-2, c-Fos, and c-Jun proteins. Cultures were exposed for 4 h to increasing concentrations of CHX, and then were immunostained with antibodies to Bcl-2, c-Fos, and c-Jun. Relative levels of neuronal immunoreactivity were quantified (see Materials and Methods). Photomicrographs of control and CHXtreated cells immunostained with bcl-2 and c-*fos* antibodies are shown in Fig. [5](#F5){ref-type="fig"} *A.* CHX induced concentration- dependent increases in levels of Bcl-2, c-Fos, and c-Jun, with maximum increases occurring in neurons exposed to 100 nM CHX (Fig. [5](#F5){ref-type="fig"} *B*). Higher concentrations of CHX did not increase levels of any of the three proteins.

CHX Suppresses FeSO~4~-induced Accumulation of Reactive Oxygen Species, and Depletion of an Endogenous Antioxidant Reduces the Neuroprotective Efficacy of CHX
--------------------------------------------------------------------------------------------------------------------------------------------------------------

Since neuroprotective concentrations of CHX induced increased levels of *bcl-2* mRNA and protein, and since bcl-2 is known to have antioxidant functions ([@B36]; [@B38]), we determined whether pretreatment of hippocampal cultures with CHX would reduce levels of oxidative stress in neurons exposed to FeSO~4~. Cultures were pretreated with vehicle or 100 nM CHX, and then exposed to FeSO~4~ for 20 min. Levels of peroxides were quantified using the DCF probe, and confocal laser scanning microscopy ([@B29]). FeSO~4~ induced a large increase in peroxide levels (Fig. [6](#F6){ref-type="fig"}, *A* and *B*). The FeSO~4~-induced increase of peroxide was attenuated in neurons pretreated with 100 nM CHX (Fig. [6](#F6){ref-type="fig"} *B*), but not with higher or lower concentrations of CHX (10 nM and 1 μM; data not shown), demonstrating that a neuroprotective concentration of CHX reduces oxidative stress.

If the mechanism whereby CHX protected neurons involved enhancement of antioxidant pathways, then depletion of antioxidants should prevent protection by CHX. Buthionine sulfoximine (BSO) is an agent that causes glutathione depletion by irreversibly inhibiting γ-glutamylcysteine synthase, an enzyme required for glutathione synthesis ([@B34]). Hippocampal cultures were pretreated with vehicle or 100 nM CHX for 16 h, and then were exposed for 20 h to glutamate alone or in combination with 150 μM BSO. BSO significantly reduced the excitoprotective effect of CHX (Fig. [6](#F6){ref-type="fig"} *C*). BSO alone was not toxic during a 20-h exposure period.

Bcl-2 Antisense Oligodeoxynucleotides Abrogate the Neuroprotective Actions of CHX
---------------------------------------------------------------------------------

Previous studies used antisense approaches to demonstrate roles for Bcl-2 in prevention of cell death in several cell death paradigms ([@B42]; [@B2]; [@B41]). In preliminary studies we showed that exposure of cultured hippocampal neurons to 10--50 μM of a Bcl-2 antisense ODN for 16 h resulted in a decrease in levels of Bcl-2 protein as determined by immunocytochemistry (Fig. [7](#F7){ref-type="fig"} *A*) and Western blot analysis (Fig. [7](#F7){ref-type="fig"} *B*). The ability of 100 nM CHX to protect neurons against glutamate toxicity in Bcl-2 antisense ODN-pretreated cultures and control (missense ODN- or vehicle-pretreated cultures) was then determined. Pretreatment with Bcl-2 antisense ODN significantly reduced the neuroprotective action of CHX, whereas the control ODN had no effect on the neuroprotective efficacy of CHX (Fig. [8](#F8){ref-type="fig"}). 20--35% of the neurons survived exposure to glutamate in the absence of CHX and in cultures pretreated with Bcl-2 antisense ODN plus CHX, whereas 50--65% of the neurons survived in cultures pretreated with CHX alone or CHX plus control ODN. Bcl-2 antisense and missense ODNs (Fig. [8](#F8){ref-type="fig"}), and sense and nonsense ODNs (data not shown), alone had no effect on neuronal survival during a 48-h exposure period.

CHX Increases Antioxidant Enzyme Activity Levels in Hippocampal Cultures
------------------------------------------------------------------------

Several different neurotrophic factors that protect neurons against the kinds of oxidative insults examined in the present study have been shown to induce the expression of one or more antioxidant enzymes in several types of neurons including hippocampal neurons ([@B37]; [@B65]). Since CHX suppressed accumulation of H~2~O~2~ and toxicity of oxidative insults, we quantified activities of the antioxidant enzymes catalase, Cu/Zn-SOD, and Mn-SOD in control hippocampal cultures and in cultures pretreated for 24 h with increasing concentrations of CHX. Activities of all three antioxidant enzymes were significantly increased in cultures treated with 100--500 nM CHX (Fig. [9](#F9){ref-type="fig"}). Lower or higher concentrations of CHX did not affect antioxidant enzyme activities.

Discussion
==========

The ability of CHX to protect cultured hippocampal neurons against the toxicities of glutamate, FeSO~4~, and Aβ is in general agreement with previous reports in various cell culture models. CHX protected cultured retinal ganglion cells against NMDA toxicity ([@B21]), protected PC12 cells against glutamate toxicity ([@B76]), and protected cultured cortical neurons against oxidative injury ([@B73]) and Aβ toxicity ([@B81]). In such prior studies, a single concentration of CHX was usually used and concentration--effect analyses were not performed. Our data clearly show that the neuroprotective actions of CHX in hippocampal cultures are concentration dependent with significant effects being observed within the range of 50--500 nM CHX. It was reported that only intermediate doses of CHX protect neurons against ischemic injury in adult rats in vivo ([@B82]), a finding consistent with our cell culture data. Moreover, [@B68] directly demonstrated that low concentrations of CHX that have a negligible effect on protein synthesis can induce a large increase in inducible nitric oxide synthase mRNA levels in cultured macrophages. Several lines of evidence in the present study suggest that the neuroprotective actions of CHX were not the result of inhibition of protein synthesis. First, the most effective concentrations of CHX (50--100 nM) were considerably lower than the concentrations required to inhibit protein synthesis maximally in most cell types and, in our cultures, caused only a 40% reduction in incorporation of radiolabeled amino acids into TCA-precipitable protein. Second, higher micromolar concentrations of CHX that inhibited protein synthesis maximally were ineffective in protecting neurons against the excitotoxic and oxidative insults. Third, neuroprotective concentrations of CHX induced increases in levels of Bcl-2, c-Fos, and c-Jun protein (and their encoding mRNAs); increased production of these proteins argues against a general inhibition of protein synthesis at those CHX concentrations. Finally, neuroprotective concentrations of CHX induced increased activity levels of the antioxidant enzymes catalase, Cu/ZnSOD, and Mn-SOD.

It is increasingly recognized that apoptosis and necrosis often represent different manifestations of cell death that, nevertheless, share common underlying mechanisms. Indeed, the same initiator of cell death can kill the same cell type by either apoptosis or necrosis depending upon intensity/duration parameters of the insult ([@B3]). In the present study CHX protected hippocampal neurons against three different insults that are known to engender both apoptosis and necrosis. Our previous studies ([@B60]; [@B51]) and unpublished data from studies of rat hippocampal cell cultures (M.P. Mattson and R.J. Mark) indicate that (at the concentrations used in the present study) glutamate and FeSO~4~ kill neurons mainly by necrosis, whereas Aβ induces mainly apoptotic death (see also [@B49]). The mechanisms of toxicities of these three insults have been well characterized in previous studies. Glutamate induces calcium influx through NMDA receptors and voltage- dependent channels, and the elevated calcium levels induce production of superoxide anion radical ([@B44]) and H~2~O~2~ ([@B65]), probably by disrupting mitochondrial transmembrane potential ([@B64]). FeSO~4~ kills neurons by inducing hydroxyl radical production and lipid peroxidation; activation of NMDA receptors also contributes to FeSO~4~ neurotoxicity in hippocampal cell cultures ([@B85]). Aβ induces membrane oxidation ([@B9]; [@B5]), which impairs function of ion- motive ATPases ([@B51], 1997*a*) and glucose ([@B54]) and glutamate ([@B40]) transporters, resulting in membrane depolarization and calcium influx; both free radicals and calcium appear to contribute to the neurotoxicity of Aβ ([@B52]). Our data indicate that the mechanism whereby CHX protects neurons against these different insults is by enhancing antioxidant defense systems. As evidence, we found that neuroprotective concentrations of CHX induce increased levels of Bcl-2. Moreover, exposure of hippocampal cultures to Bcl-2 antisense oligonucleotides reduced Bcl-2 levels and abrogated the neuroprotective effects of CHX. These findings suggest that the increase in Bcl-2 induced by neuroprotective concentrations of CHX was mechanistically linked to neuroprotection. Many different studies of both apoptotic and necrotic cell death paradigms have shown that Bcl-2 can protect cells against oxidative insults ([@B36]; [@B26]; [@B39]). Measurements of levels of reactive oxygen species including H~2~O~2~ have shown that expression of Bcl-2 is correlated with reduced levels of oxidative stress in cells exposed to oxidative insults ([@B38]). Consistent with a role for Bcl-2 in the neuroprotective actions of CHX, we found that pretreatment of hippocampal neurons with neuroprotective concentrations of CHX resulted in a significant attenuation of FeSO~4~-induced accumulation of cellular H~2~O~2~. In addition, we found that activity levels of three different antioxidant enzymes were increased in CHX-treated cultures. It is known that oxidative stress itself can induce expression of immediate early gene products and antioxidant enzymes ([@B28]). However, we did not detect an increase in levels of H~2~O~2~ in cultured hippocampal neurons exposed to neuroprotective concentrations of CHX, suggesting that CHX was likely acting by a more direct effect on expression of the antioxidant enzymes. Another potential mechanism by which CHX might increase resistance to oxidative insults is suggested by the work of Ratan et al. (1994*b*) who showed that CHX can enhance cellular antioxidant pathways by shunting cysteine from protein synthesis to glutathione. Consistent with the latter mechanism, we found that BSO, which depletes cellular glutathione levels, significantly reduced the excitoprotective efficacy of CHX. The cumulative data therefore suggest that there may be several mechanisms, each involving enhancement of antioxidant pathways, whereby CHX protects neurons against excitotoxic and oxidative insults. Our data suggest that, in the cell death paradigms examined in the present study, the neuroprotective mechanism of CHX involves induction of cytoprotective gene products involved in antioxidant pathways rather than suppression of killer gene products. However, because the neuroprotective concentrations of CHX did cause a modest 20% decrease in overall protein synthesis, we cannot completely rule out the possibility that a selective inhibition of production of death genes occurred under those conditions.

The similarities between the neuroprotective actions of CHX demonstrated in the present study and the neuroprotective actions of neurotrophic factors documented in prior studies (for review see [@B62]) are striking. Pretreatment of hippocampal cell cultures with bFGF, NGF, and BDNF protected neurons against glutamate toxicity and suppressed accumulation of reactive oxygen species ([@B60]; [@B13]; [@B65]). bFGF and NGF also protected cultured hippocampal neurons against FeSO~4~ toxicity ([@B85]). bFGF ([@B62]) and BDNF (Mattson, M.P., unpublished data) protected cultured hippocampal neurons against Aβ toxicity. Each of these neurotrophic factors has been shown to induce the expression of one or more gene products linked to resistance to oxidative insults. Examples include: bFGF induced Cu/Zn-SOD and glutathione reductase in hippocampal cell cultures and protected neurons against glutamate toxicity ([@B65]); NGF induced catalase expression in PC12 cells and protected them against H~2~O~2~ toxicity ([@B37]); BDNF induced glutathione peroxidase in striatal neurons and protected them against metabolic/excitotoxic insults ([@B77]); and PDGF induced a doubling of catalase and Cu/Zn-SOD activity levels in hippocampal cultures and protected neurons in those cultures against FeSO~4~- and glucose deprivation--induced injury (Cheng et al., 1995). None of the latter studies examined the effects of the trophic factors on Bcl-2 levels. However, recent data suggest that BDNF can induce *bcl-2* expression in neurons that are dependent upon BDNF for survival, and that Bcl-2 may mediate the survival response to BDNF ([@B2]). Since we found that Bcl-2 antisense blocked the neuroprotective effects of CHX, the contribution of CHXinduced increases in antioxidant enzyme activities to the neuroprotective action of CHX remains to be established.

While it is well documented that CHX can increase levels of immediate early gene mRNAs ([@B31]), our demonstrations of increased levels of immediate early gene proteins and antioxidant enzyme activities are novel findings. The mechanism whereby CHX induces increased levels of immediate early gene products and antioxidant enzymes may involve stimulation of transcription and/or stabilization of mRNAs. We found that neuroprotective concentrations of CHX induced an increase in c-*fos* hnRNA, indicating that, at least for this gene, CHX can induce transcription. Consistent with our findings are previous data showing that CHX can induce activation of transcription factors ([@B31]; [@B79]; [@B86]). On the other hand, CHX has also been shown to reduce degradation of certain mRNAs ([@B23]) and could, in that way, increase mRNA levels. Such actions of CHX at concentrations below those that inhibit protein synthesis could, in theory, result in increased protein synthesis. Indeed, our data suggest that levels of c-Fos, c-Jun, and Bcl-2 were increased in cultures exposed to neuroprotective concentrations of CHX.

Taken together with previous findings, the present data suggest that CHX can suppress cell death by two quite different mechanisms, one involving suppression of production of presumptive death genes, and the other involving induction of expression of cytoprotective gene products. Some prior studies have provided strong evidence that CHX can suppress cell death by inhibiting protein synthesis. For example, in sympathetic neurons where CHX acts at higher concentrations, CHX may suppress cell death by inhibiting synthesis of killer gene products ([@B56], 1992). However, in most studies that have used CHX to block cell death, the extent to which the cytoprotective concentrations of CHX suppressed protein synthesis was not determined. Moreover, in in vivo studies of cerebral ischemia and other insults that have documented neuroprotective actions of CHX, no information was obtained concerning levels of protein synthesis in the "saved" neurons (e.g., [@B30]; [@B47]; [@B80]; [@B82]). The collective data from the present study demonstrate that CHX protects cortical neurons against insults relevant to the pathogenesis of ischemic and excitotoxic brain injury by inducing production of antioxidant gene products. Therefore, we suggest that the fact that CHX protects neurons against a particular insult does not justify the conclusion that death genes are involved in the cell death process. It will be necessary to rigorously evaluate the mechanism of neuroprotection by CHX in each paradigm and, ultimately, to identify specific life gene products that are induced, or death gene products that are suppressed.
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CHX

:   cycloheximide
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![CHX protects cultured hippocampal neurons against excitotoxic and oxidative insults in a concentration-dependent manner. Cultures were preincubated for 16 h with vehicle or the indicated concentrations of CHX, and then were exposed to 10 μM glutamate (*A*), 5 μM FeSO~4~ (*B*), 5 μM Aβ (*C*), or vehicle control (*D*). Neuronal survival was quantified 20 h later. Values represent the mean and SEM (*n* = 4 separate cultures). \**P* \< 0.05, \*\**P* \< 0.01 compared with 0 CHX value. ANOVA with Scheffe\'s post-hoc tests.](JCB.furukawa1){#F1}

![(*A*) Time course of effects of neuroprotective (*100 nM*) and high (*10 μM*) concentrations of CHX on protein synthesis. Cultures were exposed to 100 nM or 10 μM CHX for 1, 4, 12, or 24 h, and incorporation of \[^35^S\]methionine into TCA-precipitable protein was quantified. Values are the mean and SEM of determinations made in three separate cultures. For 100 nM CHX, the 1 h value was significantly less than the 0 h value (*P* \< 0.05). For 10 μM CHX, the 1, 4, 12, and 24 h values were each significantly less than the 0 h value and each value for cultures exposed to 100 nM CHX (*P* \< 0.001). (*B*) Effect of increasing concentrations of CHX on protein synthesis. Cultures were exposed for 1 h to the indicated concentrations of CHX, and incorporation of \[^35^S\]methionine into TCA-precipitable protein was quantified. Values are the mean and SEM of determinations made in three separate cultures. The values for cultures exposed to either 100 or 300 nM CHX were different than the values for cultures exposed to 0 (*P* \< 0.01), 10 (*P* \< 0.05), 1,000 (*P* \< 0.001), and 10,000 (*P* \< 0.001) nM CHX. Statistical comparisons used ANOVA with Scheffe\'s post-hoc tests.](JCB.furukawa2){#F2}

###### 

Neuroprotective concentrations of CHX induce expression of c-*fos*, *bcl-2*, and c-jun mRNAs. Hippocampal cultures were exposed for 1 h to the indicated concentrations of CHX (*A* and *B*), or were exposed to 100 nM CHX for the indicated time periods (*C*). RNA was isolated, and c-*fos*, c-jun, *bcl-2*, and neurofilament (*NFM*) mRNAs were amplified by RT-PCR. Data in *B* and *C* are representative of at least three independent experiments.
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###### 

Neuroprotective concentrations of CHX induce c-*fos* transcription. Cultures were exposed for 1 h to the indicated concentrations of CHX and RNA was isolated. (*A*) RT-PCR analysis of RNA amplified with c-*fos*, c-jun, and NFM primers. Locations of c-*fos* heteronuclear RNA (*hnRNA*) and mRNA are indicated at the left. Levels of c-*fos* hnRNA were increased in cells exposed to 100 and 300 nM CHX, but not in cells exposed to 1 μM CHX. (*B*) Relative levels of c-*fos* mRNA and c-*fos* hnRNA in cultures exposed for 1 h to the indicated concentrations of CHX. Similar results were obtained in three independent experiments.
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###### 

CHX induces a concentration-dependent increase in levels of Bcl-2, c-Fos, and c-Jun protein in cultured hippocampal neurons. (*A*) Cultures were exposed for 5 h to vehicle or 100 nM CHX. Cultures were then immunostained with antibodies to c-Fos or Bcl-2. Note increased nuclear c-Fos and Bcl-2 immunoreactivities in neurons exposed to CHX compared with neurons in control cultures. (*B*) Relative levels of immunoreactivity of neurons with antibodies to c-Fos, Bcl-2, or c-Jun were determined in cultures exposed for 5 h to the indicated concentrations of CHX. Staining intensity was rated on a scale from 0 to 4 (0, no staining; 1, weak; 2, moderate; 3, strong; 4, very strong). Values are the mean and SEM of determinations made in three separate cultures (100 neurons scored per culture). \**P* \< 0.01 compared with corresponding value for cultures not exposed to CHX; ANOVA with Scheffe\'s post-hoc tests.
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###### 

Neuroprotective concentrations of CHX suppress H~2~O~2~ accumulation induced by FeSO~4~. (*A*) Representative confocal laser scanning microscope images of DCF fluorescence in neurons in a vehicletreated control culture (*left*), a culture exposed to 10 μM FeSO~4~ for 20 min (*middle*), and a culture that had been pretreated with 100 nM CHX for 16 h and then exposed to 10 μM FeSO~4~ for 20 min (*right*). Fluorescence intensity is represented by the color scale at the lower left. (*B*) Cultures were preincubated for 16 h with 100 nM CHX or vehicle (*Control* and *FeSO~4~*), and then were loaded with 2,7-dichlorofluorescin diacetate and exposed to vehicle or 10 μM FeSO~4~ for 20 min. Average fluorescence in neuronal cell bodies was quantified (see Materials and Methods). Values are the mean and SEM of determinations made in a total of 30--48 neurons in three separate cultures. \**P* \< 0.02; ANOVA with Scheffe\'s post-hoc test. (*C*) Hippocampal cultures were pretreated with vehicle or 100 nM CHX for 16 h, and then were exposed for 20 h to glutamate alone or in combination with BSO as indicated. Values are the mean and SEM of determinations made in four separate cultures. \**P* \< 0.05; ANOVA with Scheffe\'s post-hoc test.
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###### 

Exposure of hippocampal cell cultures to Bcl-2 antisense oligodeoxynucleotide decreases levels of Bcl-2. (*A*) Parallel cultures were exposed for 16 h to 50 μM control (sense) ODN or 50 μM Bcl-2 antisense ODN. Cultures were then fixed and immunostained in parallel using an anti--Bcl-2 primary antibody. Shown are phase-contrast (*left*) and bright-field (*right*) micrographs. Note that levels of Bcl-2 immunoreactivity are greater in neurons in the control culture than in the culture exposed to Bcl-2 antisense ODN (*arrowheads* point to neuron cell bodies). (*B*) Cultures were exposed for 16 h to vehicle (water), 50 μM Bcl-2 antisense ODN, or 50 μM sense ODN. Solubilized proteins were electrophoretically separated, transferred to a nitrocellulose sheet, and immunoreacted with a Bcl-2 antibody. Levels of Bcl-2 were markedly decreased in the culture exposed to Bcl-2 antisense ODN compared with the control cultures.

![](JCB.furukawa7a)

![](JCB.furukawa7b)

![Blockade of the neuroprotective actions of CHX in cultures treated with *bcl-2* antisense oligodeoxynucleotide. Cultures were pretreated for 12 h with 10 or 50 μM *bcl-2* antisense ODN (bcl-2 *AS*) or control missense ODN (*MS*). Cultures were then exposed to vehicle (saline) or 100 nM CHX for 16 h, followed by a 20-h exposure to vehicle (saline) or 10 μM (*A*) or 50 μM (*B*) glutamate (*Glut*) in the continued presence of ODN. Neuronal survival was quantified and values (mean and SEM; *n* = 3 cultures) are expressed as a percentage of the initial number of neurons. \**P* \< 0.05; \**P* \< 0.01.](JCB.furukawa8){#F8}

![CHX induces increases in antioxidant enzyme activities in cultured hippocampal cells. Cultures were exposed to the indicated concentrations of CHX for 24 h. Activity levels of catalase, Cu/Zn-SOD, and Mn-SOD in cell homogenates were then quantified. Values are expressed in units of enzyme activity per mg protein and represent the mean and SEM of determinations made in three separate cultures. \**P* \< 0.01 compared with corresponding cultures not exposed to CHX.](JCB.furukawa9){#F9}
